| Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase | |
Wu, Mingyi1; Wen, Dandan1,2; Gao, Na1; Xiao, Chuang1,3 ; Yang, Lian1; Xu, Li1; Lian, Wu1,3; Peng, Wenlie3; Jiang, Jianmin2; Zhao, Jinhua1; Jiang,JM (reprint author),Sun Yat Sen Univ,Sch Pharmaceut Sci,Guangzhou 510006,Guangdong,Peoples R China.; lssjjm@mail.sysu.edu.cn; zhao.jinhua@yahoo.com
| |
| 2015-03-06 | |
| 发表期刊 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
 |
| 卷号 | 92页码:257-269 |
| 摘要 | Fucosylated chondroitin sulfate (FCS), a structurally unusual glycosaminoglycan, has distinct anticoagulant properties, and is an especially strong inhibitor of the intrinsic factor Xase (anti-Xase). To obtain a highly selective inhibitor of human Xase, we purified six native FCSs with various sulfation patterns, prepared a series of FCS derivatives, and then elucidated the relationship between the structures and the anticoagulant activities of FCSs. FCSs 1-3 containing higher Fuc2S4S exhibit stronger AT-dependent anti-IIa activities, whereas 4-6 containing more Fuc3S4S produce potent HCII-dependent anti-IIa activities. Saccharides containing a minimum of 6-8 trisaccharide units, free carboxyl groups, and full fucosylation of GlcA may be required for potent anti-Xase activity, and approximately six trisaccharide units and partial fucosylation of GlcA may contribute to potent HCII-dependent activity. Decreasing of the molecular weights markedly reduces their AT-dependent anti-IIa activities, and even eliminates human platelet and factor XII activation. Furthermore, in vitro and in vivo studies suggested that fractions of 6-12 kDa may be very promising compounds as putative selective intrinsic Xase inhibitors with antithrombotic action, but without the consequences of major bleeding and factor XII activation. (C) 2014 Elsevier Masson SAS. All rights reserved. |
| 关键词 | Fucosylated Chondroitin Sulfate Factor Xase Inhibitor Anticoagulant Antithrombotic Structure-activity Relationship |
| 学科领域 | Chemistry, Medicinal |
| DOI | 10.1016/j.ejmech.2014.12.054 |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000350919100020 |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.kib.ac.cn/handle/151853/20615 |
| 专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
| 通讯作者 | Jiang,JM (reprint author),Sun Yat Sen Univ,Sch Pharmaceut Sci,Guangzhou 510006,Guangdong,Peoples R China.; lssjjm@mail.sysu.edu.cn; zhao.jinhua@yahoo.com |
| 作者单位 | 1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China 2.Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China 3.Sun Yat Sen Univ, Coll Life Sci, Guangzhou 510006, Guangdong, Peoples R China |
| 推荐引用方式 GB/T 7714 | Wu, Mingyi,Wen, Dandan,Gao, Na,et al. Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2015,92:257-269. |
| APA | Wu, Mingyi.,Wen, Dandan.,Gao, Na.,Xiao, Chuang.,Yang, Lian.,...&zhao.jinhua@yahoo.com.(2015).Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,92,257-269. |
| MLA | Wu, Mingyi,et al."Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 92(2015):257-269. |
| 条目包含的文件 | 下载所有文件 | |||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| Wu-2015-Anticoagulan（1936KB） | 开放获取 | CC BY-NC-ND | 浏览 下载 | |||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论